Trial Profile
Is second line aflibercept and FOLFIRI a tolerable and useful down-staging schedule in Ras mutant advanced colorectal cancer in a real world environment?
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Oct 2015
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 07 Oct 2015 New trial record